UniPR505

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

UniPR505 

UniPR505 (Compound 14) 是一种 EphA2 拮抗剂，IC50 值为 0.95 µM。UniPR505 表现出抗血管生成特性。

UniPR505

UniPR505 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

UniPR505 (Compound 14) is an EphA2 antagonist with an IC50 of 0.95 µM. UniPR505 displays anti-angiogenic properties[1].

IC50 & Target

IC50: 0.95 µM (EphA2), 4.4 µM (EphA5), 4.5 µM (EphA3), 6.4 µM (EphA4), 7.7 µM (EphA8), 11 µM (EphB3), 14 µM (EphB2), 18 µM (EphA6)[1]
分子量

647.89

Formula

C39H57N3O5
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Incerti M, et al. Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties. Eur J Med Chem. 2020 Mar 1;189:112083.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务